Skip to main content

Table 2 Comparisons of quality of life and symptoms between patients and controls: Results from questionnaires

From: Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study

Score

Patients

N = 376

Controls

N = 188

p-value

QLQ-C30

 QLQ-C30 Global score, median [Q1;Q3]

94.87 [87.44; 98.72]

11 DM

94.15 [89.66; 98.21]

4 DM

0.71

 Global health status/QoL:

Worse global health (<=83.3), n(%)

117 (31.3)

2 DM

49 (26.5)

3 DM

0.25

 Physical Functioning: score < 100, n (%)

136 (36.5)

3 DM

63 (34.1)

3 DM

0.58

 Role Functioning: score < 100, n (%)

71 (19)

3 DM

25 (13.5)

3 DM

0.11

 Emotional Functioning: score < 100, n(%)

204 (54.6)

2 DM

89 (48.1)

3 DM

0.15

 Cognitive Functioning: score < 100, n(%)

170 (45.6)

3 DM

99 (53.5)

3 DM

0.0799†

 Social Functioning: score < 100, n (%)

91 (24.3)

2 DM

30 (16.3)

4 DM

0.0332*

 Fatigue: score > 0, n (%)

167 (44.7)

2 DM

84 (45.4)

3 DM

0.87

 Nausea/Vomiting: score > 0, n (%)

16 (4.3)

2 DM

6 (3.2)

3 DM

0.56

 Pain: score > 0, n (%)

86 (23)

2 DM

61 (33)

3 DM

0.0131*

 Dyspnea: score > 0, n(%)

82 (22)

4 DM

23 (12.4)

3 DM

0.0078*

 Insomnia: score > 0, n (%)

128 (34.2)

2 DM

70 (37.8)

3 DM

0.40

 Appetite loss: score > 0, n (%)

19 (5.1)

4 DM

11 (6)

3 DM

0.68

 Constipation: score > 0, n (%)

69 (18.5)

3 DM

44 (23.8)

3 DM

0.15

 Diarrhea: score > 0, n (%)

53 (14.3)

5 DM

24 (13)

3 DM

0.67

 Financial Problems: score > 0, n (%)

22 (6)

10 DM

6 (3.3)

5 DM

0.18

IPSS

 Mild

254 (72.4)

141 (78.8)

0.107

 Moderate

77 (21.9)

31 (17.3)

 Severe

20 (5.7)

25 DM

7 (3.9)

9 DM

IIEF-6

 Severe erectile dysfunction

209 (65.5)

55 (32)

<  0.0001

 Moderate dysfunction

28 (8.8)

19 (11.2)

 Mild to moderate dysfunction

26 (8.2)

13 (7.6)

 Mild dysfunction

20 (6.3)

26 (15.1)

 No dysfunction

36 (11.3)

57 DM

59 (34.3)

16 DM

ICIQ-MLUTS

 Voiding score (VS)

2 [0; 5]

17 DM

2 [1; 5]

6 DM

0.78

 Incontinence score (IS)

3 [1; 6]

16 DM

2 [0; 3]

5 DM

< 0.0001

 Frequency of diurnal urination

  

0.0884

- 1–6 times per day

213 (58.4)

124 (66.3)

- 7–8 times per day

107 (29.3)

43 (23)

- ≥9 times per day

45 (12.3)

11 DM

20 (10.7)

1 DM

 Frequency of nocturnal urination

  

0.99

- Never

74 (20.1)

33 (17.9)

- 1 time per night

191 (51.9)

93 (50.5)

- ≥ 2 times per night

103 (28)

8 DM

58 (31.5)

4DM

HADS Anxiety

 Absence of anxiety

266 (74.9)

140 (77.4)

0.64

 Suspected anxiety

59 (16.6)

31 (17.1)

 Probable anxiety

30 (8.5)

21 DM

10 (5.5)

7 DM

HADS Depression

 Absence of depression

303 (85.1)

155 (87.6)

0.44

 Suspected depression

36 (10.1)

15 (8.5)

 Probable depression

17 (4.8)

20 DM

7 (4)

11 DM

HADS Total score

 Absence of anxio-depressive troubles

277 (80.8)

149 (85.6)

0.17

 Presence of anxio-depressive troubles

66 (19.2)

33 DM

25 (14.4)

14 DM

  1. Data presented as number (%) or median [IQR] as appropriate. Results presented as number (%) patients in each group with functional scores < 100 and symptom scores as > 0. DM: Data missing; *significant difference (< 5%); †potentially significant difference (5–10%)